It already picked up to the 80's and has been in freefall ever since. Operationally, this company is dead so the SP reflects that however from time to time there is either a pump and dump or some news like the acquisition which boosts it temporarily, then the market digests it and brings it back down. Long suffering shareholders have seen it time and time again since covid finished.
The £100m line was so so unrealistic and had no basis. Is there a case for misleading investors with such words? Or can they just say what they want in investor presentations reproach? Surely he has to be accountable for his words? Not saying it was deliberately to mislead but the operational performance is so far detached from that number it’s about as believable ad pigs flying.
Far too early to say that LR has had any impact on the SP. The SP debacle is fully to do with the complete lack of strategy and post pandemic revenue generation and that sits squarely on the shoulders of the current and past board. After the windfall of 2020 and all the learnings, contacts etc. they completely wasted 2021, 2022 and 2023. 3 entire years of absolute nothingness. 3 years. Unforgiveable, yet they're still there cashing their massive pay cheques.
HarChris - paying down debt would not contribute to a P&L loss, debt repayments are purely a balance sheet item. The interest expense on the debt impacts the P&L loss but not the debt repayments. Is net cash outflow being confused with 'loss' here?
30-40's by dispute time, can't see the final few months of the year changing that. We're back into the miles below cash balance territory again so there's clearly no link between that and the SP any more so there's no floor for this.
Let's face it, if any of us were not invested in this and looked at the interim results we wouldn't touch it with a barge pole so it's no surprise that it's dwindling as it is.
Is he sweating? Absolutely fine last year and the year before this last one was just as bad. I can’t even get my votes registered so no idea how many more people are in a similar vote. And I can assure you I would be voting against anything in his or the BoD’s interests. As we saw last year, those who can vote in big numbers clearly think he’s doing something right.
On that note, what does he do? And how much does he get paid from our money?
Risks? Pretty much everything - no new decent revenue streams, massive cash burn, incompetence at board level, market hates the company, bankruptcy if we lose the dispute.
Another -7% to start the week. Torrid.
val, well most small companies won’t unless there is another covid like event. however, that’s irrelevant, ncyt have the money and are doing nothing with it (your gene acquisition is a massive risk so will see how that pans out) and it is being burned at an alarming rate.
and where is the extra £30m a year from? are you referring to joint revenue, you do realise that revenue doesn’t equal cash in the bank, we have **** loads of overheads to pay for.
hc - precisely, and yet again they proved why with that awful presentation last week. if justice is served they’ll be kicked out tomorrow but we know it work. i’ve not even been able to vote. pathetic.
i’d say it’s more 36-48 months given the speed we move, don’t forget we’re miles below 2019 revenues, your gene is loss making and comes with an expensive executive who may not see eye to eye with the current crop, could cause delays. you’re right that there’s no use investing based on cash in the bank as that looks like it’ll be gone in 4 years.